Internal Medicine · Upland, CA
NPI
1558497891
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1060 E Foothill Blvd, Suite 103
Upland, CA, 91786
Phone (909) 981-8904
Groups this clinician bills Medicare through
Medicare paid, 2024
$200K
2,154 services
Medicare patients, 2024
324
Average age 74
Drug cost, 2024
$963K
10,225 prescriptions
Company payments, 2025
$390
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ghassan Hadi was code 99233 (hospital e&m - subsequent), 1,232 times for 156 patients. In total Ghassan Hadi billed 2,154 services in 19 codes, and Medicare paid $200K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,232 | 156 | $90.35 | $111K |
| 99223 Hospital E&M - Initial | Facility | 221 | 163 | $130.69 | $29K |
| 99214 Office E&M - Established | Office | 196 | 86 | $90.32 | $18K |
| 99232 Hospital E&M - Subsequent | Facility | 182 | 96 | $60.03 | $11K |
| 99239 Hospital Discharge Management | Facility | 180 | 139 | $86.69 | $16K |
| 99306 SNF E&M | Facility | 79 | 63 | $132.39 | $10K |
| 99309 SNF E&M | Facility | 21 | 17 | $72.58 | $1,524 |
By year: 2022 $220K for 2,453 services; 2023 $272K for 2,797 services; 2024 $200K for 2,154 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ghassan Hadi prescribed most often to Medicare patients was Atorvastatin Calcium, with 540 prescriptions and refills. In total Ghassan Hadi wrote 10,225 Medicare prescriptions that cost $963K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 540 | 916 | 118 | $5,398 |
| Eliquis Apixaban | 359 | 375 | 45 | $132K |
| Gabapentin Generic | 263 | 328 | 48 | $5,464 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 256 | 260 | 35 | $4,650 |
| Metformin Hcl Generic | 237 | 482 | 55 | $1,754 |
| Levothyroxine Sodium Generic | 236 | 354 | 45 | $2,464 |
| Losartan Potassium Generic | 232 | 400 | 54 | $2,250 |
| Pantoprazole Sodium Generic | 214 | 279 | 52 | $2,655 |
| Tamsulosin Hcl Generic | 189 | 306 | 38 | $3,000 |
| Amlodipine Besylate Generic | 181 | 302 | 40 | $1,160 |
| Famotidine Generic | 161 | 207 | 40 | $1,786 |
| Furosemide Generic | 157 | 206 | 33 | $853 |
| Carvedilol Generic | 151 | 199 | 31 | $1,170 |
| Lisinopril Generic | 151 | 250 | 35 | $880 |
| Metoprolol Succinate Generic | 149 | 243 | 36 | $3,013 |
Brand drugs: 1,666 claims; generic drugs: 8,470 claims; opioid claims: 395.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ghassan Hadi $390 ($390 in general payments such as food, travel and fees) from 9 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $144.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $144 |
| Amgen Inc. AMGN | 3 | $63.64 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $50.57 |
| Dexcom, Inc. DXCM | 2 | $41.47 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $25.34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 1 | $22.62 |
| Xeris Pharmaceuticals, Inc. | 1 | $21.95 |
| Lundbeck LLC | 1 | $20.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.